Preadmission Oral Anticoagulation for Atrial Fibrillation/Flutter and Death or Thrombotic Events During COVID-19 Admission

Atrial fibrillation/flutter (AF) and COVID-19 are associated with an elevated risk of arterial and venous thrombosis. Whether preadmission oral anticoagulation (OAC) for AF reduces the incidence of in-hospital death or thrombotic events among patients with COVID-19 is unknown. We identified 630 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Louis, David W., Kennedy, Kevin F., Saad, Marwan, Salber, Greg, Imran, Hafiz, Wark, Tyler, Soares, Cullen, Ghosalkar, Dhairyasheel, Cherala, Rasan, Poppas, Athena, Abbott, J. Dawn, Aronow, Herbert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374502/
https://www.ncbi.nlm.nih.gov/pubmed/35970632
http://dx.doi.org/10.1016/j.amjcard.2022.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374502/
https://www.ncbi.nlm.nih.gov/pubmed/35970632
http://dx.doi.org/10.1016/j.amjcard.2022.07.006

Ejemplares similares